Our finding that TDP-43 constitutively inhibits NF-κB pathway by blocking nuclear transportation of p65 suggests a novel mechanism of a potential anti-cancer and anti-inflammation treatment by elevating TDP-43. The gene discussed is NFKB1; the disease is cancer.